Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1

Conditions

Sarcoma, Myeloid 1Myeloproliferative Disorders 1Leukemia, Myeloid, Acute 1Blast Crisis 1

Interventions

Cyclophosphamide 30Busulfan 19Radiotherapy 18fludarabine phosphate 17Peripheral Blood Stem Cell Transplantation 17Cyclosporine 17Antilymphocyte Serum 17Filgrastim 15Mycophenolic Acid 14Methylprednisolone 13Cord Blood Stem Cell Transplantation 12Whole-Body Irradiation 10Tacrolimus 10Etoposide 10Methotrexate 9Melphalan 9Cytarabine 6Thiotepa 4sargramostim 3Therapeutics 3Sirolimus 3Flow Cytometry 3aldesleukin 2Voriconazole 2Razoxane 2Prednisone 2Polymerase Chain Reaction 2Ondansetron 2Methylprednisolone Hemisuccinate 2Methylprednisolone Acetate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blast Crisis × Gemtuzumab × Sarcoma × Clear all
NCT03589729 2026-05-22

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
MyeloidOther hematologic neoplasmSarcoma

Blast Crisis, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Sarcoma, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡